about
Half-molar sodium lactate infusion improves cardiac performance in acute heart failure: a pilot randomised controlled clinical trial.Aberrant cell cycle and apoptotic changes characterise severe influenza A infection--a meta-analysis of genomic signatures in circulating leukocytes.Is lactate the new panacea for endothelial dysfunction?A distinct influenza infection signature in the blood transcriptome of patients with severe community-acquired pneumonia.Identifying key regulatory genes in the whole blood of septic patients to monitor underlying immune dysfunctions.A novel immune biomarker IFI27 discriminates between influenza and bacteria in patients with suspected respiratory infection.Adenosine triphosphate-magnesium dichloride during hyperdynamic porcine endotoxemia: effects on hepatosplanchnic oxygen exchange and metabolism.Tin-mesoporphyrin for inhibition of heme oxygenase during long-term hyperdynamic porcine endotoxemia.Diagnoses of right-sided empyema complicating tricuspid valve endocarditis during transesophageal echocardiography.A novel sampling method to detect airborne influenza and other respiratory viruses in mechanically ventilated patients: a feasibility study.Impact of enteral feeding on gastric tonometry in healthy volunteers and critically ill patientsEffects of ultrafiltration, dialysis, and temperature on gas exchange during hemodiafiltration: a laboratory experimentCirculating interleukin-18 concentrations and a loss-of-function P2X7 polymorphism in heart failureImmune effects of interferon gamma in persistent staphylococcal sepsisThe use of echocardiographic indices in defining and assessing right ventricular systolic function in critical care researchCorrection to: The association between premorbid beta blocker exposure and mortality in sepsis-a systematic reviewThe association between premorbid beta blocker exposure and mortality in sepsis-a systematic review
P50
Q33754315-0D6ED89D-8F24-41B4-AD08-BF2DD0E4A7F1Q33847551-E9873B37-C39B-4D26-B0D3-6F648F0AF520Q35090575-07BD1A17-6B17-4082-AD39-C3486608508AQ36634029-2B38B9C6-70C7-4E9D-BBB9-086B8D918EA1Q39395374-317FF089-3C52-48A8-A7B2-8CF5D379B96DQ40157970-E8986443-0189-4202-9CA8-A1F4685D81B7Q44090886-93EC80F2-F91A-44A9-80A6-F1F900678B59Q44464669-61F02E8D-CA32-43CC-96B9-189138CBB564Q44956275-15EE9123-FFD0-41B6-8925-A0628C8E3A6FQ52581625-F764A402-08F1-4011-80AD-7CF3E3A8E902Q73772537-06930510-DDE7-41E6-BFA6-06F559B4775FQ77637015-EDEE6A8E-BBDE-4EBB-92A7-DFF7710E0C4FQ81739186-A4B14334-7DA5-4E84-A697-A4119C71A277Q83160512-D5FECA0C-3842-4E03-9BB6-F5E125A51E5FQ88779466-8B29FE5E-C49C-425F-AA8C-CB8845701130Q92405332-C52185F9-3871-4A98-A290-C77E8447F590Q93104120-1EF6DEC5-5C96-41EA-912E-0EBC6E3D3D58
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marek Nalos
@ast
Marek Nalos
@en
Marek Nalos
@es
Marek Nalos
@nl
type
label
Marek Nalos
@ast
Marek Nalos
@en
Marek Nalos
@es
Marek Nalos
@nl
prefLabel
Marek Nalos
@ast
Marek Nalos
@en
Marek Nalos
@es
Marek Nalos
@nl
P106
P1153
6603571652
P31
P496
0000-0002-7977-9410